北京新里程药业

New Journey Wansheng Pharmaceutical, a core subsidiary of the New Journey Health Group, is a Beijing-based pharmaceutical company specializing in the development, production, and commercialization of high-quality generic drugs. The company focuses on chronic disease management, with a robust portfolio in cardiovascular health, metabolic disorders, and oncology. It serves as the primary industrial platform for its parent group's integrated medical and pharmaceutical strategy, leveraging extensive GMP-certified manufacturing facilities in Beijing. The company's flagship products include widely prescribed treatments for hypertension and diabetes, such as Valsartan and Metformin. Through its integration with New Journey Health's vast hospital network, the company aims to provide affordable and effective therapeutic solutions across China.